Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Health and Human Services (HHS)
Biotech
ARPA-H bets $4.9 million on ibogaine to treat PTSD in veterans
The funding will come over a five-year period from ARPA-H and will include a a focus on veterans.
Marissa Russo
Nov 12, 2026 2:56pm
ARPA-H unveils Surpass program to accelerate clinical trials
Oct 7, 2026 11:25am
FDA launches pilot program to speed up sluggish phase 1 trials
Sep 15, 2026 2:09pm
NIH joins Trump’s $5B AI mission with biomedical research push
Jul 22, 2026 2:43pm
HHS unveils plan to speed up ph. 1 trials by 6 to 12 months
Jun 22, 2026 12:10pm
Fierce Pharma
CDER chief Høeg and CBER's Szarama exiting FDA posts
May 15, 2026 1:44pm